Skip to main content

Iris-matched conformer for immediate placement following pediatric enucleation for retinoblastoma

To design and fabricate a biocompatible, low-cost, natural-appearing iris conformer for immediate placement after surgical removal of the eye.

Project Overview

The overall goal of the iris conformer is to reduce the effect enucleation has on a young child. Retinoblastoma is the most common primary intraocular malignancy of childhood, requiring enucleation for many patients. Following enucleation surgery, an orbital implant is placed, and a temporary clear plastic conformer shell is inserted to maintain the socket shape and permit wound healing. The child then has an asymmetric appearance until the final prosthesis can be fitted in 6 to 8 weeks. Appearance-related outcomes measurably influence long-term quality of life in this patient population, yet this period of disfigurement has not been sufficiently addressed. The iris conformer will be fabricated to be biocompatible, low-cost, and natural-appearing for immediate placement after surgical removal of the eye.

Team Picture

From left to right: Matthew Klysen, Kira Gitelson, Zoey Zinger, Lucy McArdle, Keira Ferrigan, Ella Prose
From left to right: Matthew Klysen, Kira Gitelson, Zoey Zinger, Lucy McArdle, Keira Ferrigan, Ella Prose

Files

Progress Reports

Contact Information

Team Members

Advisor and Client

Back to Top